Answers are grounded in this paper and cite their sources.
Multicenter study finds multi-inflammatory markers regress after antiretroviral therapy in HIV-positive individuals, suggesting monitoring for chronic inflammation is necessary.
Multi-inflammatory markers were found to regress after antiretroviral therapies use in persons living with human immunodeficiency virus. In the long term, these patients should be monitored for the effects of chronic inflammation.
No takes yet. Share an insight, caveat, or question.
Şahin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: